Back to Search Start Over

Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 update

Authors :
Catia Duarte
Joana Sousa-Neves
Ana Águeda
Pedro Ribeiro
Alexandra Daniel
Gisela Eugénio
Sofia Serra
Filipe Araújo
Anabela Barcelos
Barcelos Filipe
Miguel Bernardes
Helena Canhão
Marcos Cerqueira
Susana Capela
Ana Cordeiro
Flavio Costa
Lucia Costa
Margarida Cruz
Luis Cunha Miranda
Catarina Duarte
Sandra Falcao
Daniela Faria
Ricardo Figueira
João Pedro Freitas
Maria João Gonçalves
João Madruga Dias
José Melo Gomes
Ana Filipa Mourão
Adriano Neto
Filipa Oliveira Ramos
Sofia Pimenta
Patricia Pinto
Joaquim Polido-Pereira
Cristina Ponte
João Ramos
Ana Rodrigues
Helena Santos
Maria José Santos
Alexandre Sepriano
Candida Silva
José Tavares Costa
Filipa Teixeira
Vitor Teixeira
Paula Valente
Elsa Vieira-Sousa
Rita Barros
Pedro Abreu
João Eurico Fonseca
Centro de Estudos de Doenças Crónicas (CEDOC)
Source :
Acta Reumatológica Portuguesa, Vol 2017, Iss 2, Pp 112-126 (2017), Universidade Nova de Lisboa, Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos), Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação, instacron:RCAAP
Publication Year :
2017
Publisher :
Sociedade Portuguesa de Reumatologia, 2017.

Abstract

OBJECTIVE: To update the recommendations for the treatment of Rheumatoid Arthritis (RA) with biological therapies, endorsed by the Portuguese Society of Rheumatology (SPR). METHODS: These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion. At a national meeting the 10 recommendations were discussed and updated. The document resulting from this meeting circulated to all Portuguese rheumatologists, who anonymously voted online on the level of agreement with the recommendations. RESULTS: These recommendations cover general aspects as shared decision, prospective registry in Reuma.pt, assessment of activity and RA impact and treatment objective. Consensus was also achieved regarding specific aspects as initiation of biologic therapy, assessment of response, switching and definition of persistent remission. CONCLUSION: These recommendations may be used for guidance of treatment with biological therapies in patients with RA. As more evidence becomes available and more therapies are licensed, these recommendations will be updated. publishersversion published

Details

Language :
English
Volume :
2017
Issue :
2
Database :
OpenAIRE
Journal :
Acta Reumatológica Portuguesa
Accession number :
edsair.pmid.dedup....25460c22d6a006a34a0fd2d7c68dd0a2